IIM
BMRN icon

INTECH Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

INTECH Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,497
Closed -$1.89M – 2129
2026
Q1 		$1.89M Buy
33,497
+29,684
+778% +$1.73M 0.02% 727
2025
Q4 		$227K Sell
3,813
-11,329
-75% -$617K ﹤0.01% 1916
2025
Q3 		$820K Sell
15,142
-672
-4% -$38.4K 0.01% 1294
2025
Q2 		$869K Sell
15,814
-16,318
-51% -$961K 0.01% 1277
2025
Q1 		$2.27M Sell
32,132
-129,603
-80% -$8.72M 0.02% 686
2024
Q4 		$10.6M Buy
161,735
+107,879
+200% +$7.23M 0.1% 160
2024
Q3 		$3.79M Sell
53,856
-4,167
-7% -$348K 0.04% 321
2024
Q2 		$4.78M Buy
58,023
+21,669
+60% +$1.8M 0.06% 263
2024
Q1 		$3.18M Buy
36,354
+11,186
+44% +$1M 0.04% 294
2023
Q4 		$2.43M Sell
25,168
-3,949
-14% -$349K 0.04% 313
2023
Q3 		$2.58M Buy
29,117
+1,237
+4% +$110K 0.04% 318
2023
Q2 		$2.42M Buy
27,880
+3,537
+15% +$333K 0.02% 353
2023
Q1 		$2.37M Buy
24,343
+10,539
+76% +$1.09M 0.02% 438
2022
Q4 		$1.43M Buy
13,804
+706
+5% +$66.3K 0.01% 475
2022
Q3 		$1.11M Sell
13,098
-11,131
-46% -$991K 0.01% 495
2022
Q2 		$2.01M Buy
+24,229
New +$1.93M 0.01% 451

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

INTECH Investment Management's BMRN Position: Q2 2026 in Review

INTECH Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2026, closing a stake of 33,497 shares — an estimated $1.89M sold.

INTECH Investment Management first reported a position in BMRN in Q2 2022 and held it in 16 quarters. The position peaked at $10.6M in Q4 2024. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • INTECH Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 33,497 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $1.89M.
  • INTECH Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2022 and held it in 16 quarters.
  • INTECH Investment Management's BioMarin Pharmaceuticals position peaked at $10.6M in Q4 2024.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.